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Abstract 
Although metanephric adenoma (MA) is a
rare, benign neoplasm of epithelial cells, it is
often difficult to distinguish this entity from
other malignant neoplasms preoperatively. We
report a case of a large renal mass for which
preoperative  diagnosis  was  indeterminate,
with  the  differential  diagnosis  including
Wilm’s tumor, MA, and papillary renal cell car-
cinoma (PRCC). Accurate postoperative differ-
entiation of MA from PRCC is critical because
adjuvant therapy is considered after surgical
resection of PRCC tumors. 
Introduction
Metanephric  neoplasms  comprise  a  spec-
trum of kidney tumors containing renal epithe-
lial or stromal cells or both.
1Metanephric aden  -
oma (MA) is a rare neoplasm, accounting for
0.2% of adult renal epithelial neoplasms.
2 The
majority of cases occurs in patients 50-60 years
of age
3-5 and is seen predominantly in females
by a 2:1 ratio.
4 Although MA is usually benign,
a few cases of metastatic disease have been
reported.
1,6 Several diseases can resemble MA
including  Wilm’s  tumor,  metastatic  lung
carcin  oma,  and  metastatic  papillary  thyroid
carcinoma; however, it is most difficult to dis-
tinguish MA from papillary renal cell carcino-
ma (PRCC). We describe here a case of a large
renal mass and the challenge of establishing a
preoperative diagnosis. 
Case Report
A 28-year-old woman presented with a his  -
tory  of  three  urinary  tract  infections  in  the
course  of  six  months,  and  associated  right
flank pain with no hematuria or weight loss.
She reported frequent urination of 6-8 times a
day and urethral tingling at the end of urina-
tion. During one of these infections, she was
treated with ciprofloxacin because the urine
culture  was  positive  for  enterococcus.
However, when she experienced similar symp-
toms a month later, both urinalysis and urine
cultures were negative at that time. Because
nephrolithiasis  was  suspected  as  a  possible
cause of recurrent urinary tract infections, a
non-contrast computer tomography (CT) scan
of the abdomen was performed. A large hetero-
geneous soft tissue mass (7.6¥10.6¥7.3 cm)
was found arising from the superior pole of the
right kidney and displacing the liver anteriorly.
Hyperdense areas within the mass were con-
sistent  with  recent  hemorrhages.  A  small
amount of fluid was found adjacent to the mass
and in the dependent pelvis. A left-sided para-
aortic lymph node measuring 1.1 cm was seen,
as well as several small lymph nodes in the
mesentery.  The  liver,  spleen,  and  pancreas
were  unremarkable,  and  the  left  kidney
showed no evidence of mass or hydronephro-
sis. Magnetic resonance angiography (MRA)
revealed  intra-renal  arteries  draped  around
the mass, although no definite tumor vascular-
ity was seen and the tumor did not extend into
the renal veins or inferior vena cava. MRA also
revealed a normal renal artery, two renal veins,
and a ureter on the right side. Magnetic reso-
nance imaging (MRI) detected no fat within
the mass (Figure 1). Sagittal T1-weighted and
axial T2-weighted MRI showed no evidence of
metastatic disease in the brain. 
The possibility of hydatid cyst or parasitic
infection  was  considered  in  the  differential
diagnosis  owing  to  the  unusual  multicystic
appearance of the mass with peripheral vascu-
lar  supply  and  recent  exposure  to  parasites
endemic to Paraguay. No detectable levels of
echinococcus antibody or Entamoeba histolyt  -
ica antibody were observed in ELISA analysis.
In  addition,  the  sedimentation  rate  and  C-
react  ive protein level were within the normal
range,  indicating  that  the  mass  was  not  an
abscess or parasitic infection. The peripheral
blood count and hemoglobin level were normal. 
Preoperative diagnosis was indeterminate,
with the differential diagnosis still including
Wilm’s tumor, MA, and metastatic PRCC. Given
the size of the mass and possibility of malig-
nant disease, a radical nephrectomy was per-
formed. Although the resected tumor was well
circumscribed with a pseudocapsule, it was not
well encapsulated. The mass was tan in color,
measuring  10¥6.5¥7.5  cm  and  involving  the
upper pole and the middle portion of the kid-
ney. On the cut surface, the tumor was well cir-
cumscribed, tan and lobulated, with multiple
foci  of  hemorrhage  and  one  focus  of  cystic
degeneration. The tumor extended to, but not
through, the renal capsule and occluded the
upper pole collecting system at the renal pelvis. 
Microscopically, the tumor was demarcated
from the surrounding renal parenchyma by a
pseudocapsule  of  variable  thickness.  Archi  -
tecturally, the tumor was retiform, micropapil-
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Figure 1. Magnetic resonance angiography
image of the pelvis and abdomen in the
axial (A) and coronal (B) planes. Arrows
indicate  the  location  of  a  large  mass
(7.6¥10.6¥7.3 cm).[page 104] [Rare Tumors 2010; 2:e38]
lary, and cystic (Figure 2A and B), with focal
necrosis and hyaline change. It had numerous
slit-like  spaces  and  micropapillae  lined  by
small epithelial cells with very scant cytoplasm
and oval nuclei showing delicate chromatin,
grooves, and focal small nucleoli (Figure 2C).
Mitotic figures were very rare. The septa and
fibrovascular  cores  of  the  tumor  varied  in
thickness  and  showed  hyalinization,  edema,
and numerous psammoma bodies (Figure 2D).
No calcifications were evident.
Immunohistochemically, the tumor showed
diffuse positive staining for CD57 (Figure 2E)
and WT-1 (Figure 2F), and was only very focal-
ly, weakly positive for cytokeratin 7 and epithe-
lial membrane antigen (EMA). Immunostain
for  racemase  (P504s)  was  negative  in  the
tumor. Interphase cytogenetic studies by fluor  -
escent  in  situ hybridization  showed  no  evi-
dence of trisomy for chromosomes 7 or 17. 
PRCC is associated with a gain of chromo-
somes 7 and 17 and loss of sex chromosome Y,
whereas the number of these chromosomes in
MA is normal.
7 PRCC is also characterized by
the  presence  of  enlarged  cytoplasm,  large
nucleoli, and strongly positive CK7 and EMA
immunoreactions,
8 although  two  cases  have
been reported with only focal and weak EMA
immunoreactions.
3 In our case, the only con-
siderations that supported a diagnosis of PRCC
were CK7 positivity and very focal and weak
EMA positivity. The predominance of epithelial
cells  also  excluded  a  diagnosis  of  Wilm’s
tumor,  which  is  characterized  by  epithelial,
stromal, and blastemal components. A diagno-
sis of oncocytoma was excluded by the lack of
oncocytic  cells  (granular  eosiniphilic  cells),
absence  of  CK8  and  CK18  expression,  and
absence of chromosomal abnormalities (such
as loss of chromosomes Y, 1, and 14; absence of
translocation of chromosome 11; and gain of
chromosome 12). Based on these histolologic
and  cytogenetic  features,  a  diagnosis  of  MA
was suggested. The patient remains disease
free 28 months following right nephrectomy.
Discussion
MA is a rare neoplasm that often presents as
asymptomatic, although symptoms can include
abdominal pain, abdominal mass, hematuria,
dysuria, fever, or hypertension. Among renal
lesions, MA has the highest incidence (12%)
of  polycythemia.
9 MA  tumors  appear  tan  in
color  with  multiple  foci  of  hemorrhage.
9
Calcifications are uncommon, and only occur
in approximately 20% of cases.
9 MA is com-
posed of tightly packed uniform small epithe-
lial  cells  with  small  regular  nuclei,  a  high
nuclei-to-cytoplasm ratio, and no mitotic fig-
ures. The differential diagnosis of renal MA
includes PRCC and epithelial Wilm’s tumor.
10-12
In our case, diffuse positive immunostaining
of the tumor for CD57 and WT-1, weak or neg-
ative staining for cytokeratin 7 and EMA, neg-
ative immunostaining for racemase, and the
lack  of  trisomy  for  chromosomes  7  and  17
argued against a diagnosis of PRCC, while the
patient’s age, lack of prominent nucleoli and
mitotic  activity  in  the  tumor,  and  positive
immunostaining  for  CD57  argued  against  a
diagnosis of Wilm’s tumor.
10-12
Although MA is usually benign,
13 a few cases
of metastatic disease have been reported.
1,6,14
Several diseases can resemble MA, but it is
most important to distinguish MA from PRCC.
Currently, neither ultrasound nor CT scans can
reveal  distinct  features  of  MA.  Ultrasound
scans show both hyperechoic and hypoechoic
regions, while CT scans show a non-distinct
mass
4 with low attenuation on contrast stud-
ies.
13 Fine needle aspiration can be used as
another less invasive method to diagnose MA,
but  it  is  not  as  accurate  as  nephrectomy.
Cytological diagnosis using fine needle aspira-
tion can be difficult.
15 Despite being a benign
lesion,  MA  should  be  routinely  resected  in
order to confirm the diagnosis and rule out
PRCC. In our case, continued growth of the
tumor  would  also  have  caused  morbidities
more severe than frequent urination, urinary
tract infections, and flank pain. 
Patients with MA profiles similar to that of
our patient have remained tumor-free for four
to five years after nephrectomy.
3 Based on this
previous clinical experience and the well-dif-
ferentiated nature of MA epithelial cells, we
believe that the present case of MA will follow
a benign course. A reliable postoperative dif-
ferentiation  of  MA  and  PRCC  is  relevant  to
appropriate clinical management, specifically
with regard to the benefit of adjuvant therapy.
In our case, no additional adjuvant therapy was
required.
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